Congratulations to all EAS Competitive Grants recipients 2023!
One of the aims of the Society is to ensure that research in the Atherosclerosis field continues to thrive for years to come. To achieve this, we are committed to encouraging talented young scientists in their careers within the Atherosclerosis field.
We are delighted to announce the winners for this year’s EAS Competitive Grants for Young Researchers 2023. The list of winners is arranged alphabetically.
Lorenzo Da Dalt
Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti” (DiSFeB), University of Milan (UNIMI), Italy
Project: Unveiling the impact of systemic and hepatic mitochondrial dynamism in the development of dysmetabolic disease
“I would like to express my gratitude for being granted by the EAS. I am thankful to the evaluation committee for giving me this possibility and I am truly delighted for this chance to start creating my own research in the field of Atherosclerosis.
This grant is for me a great opportunity to tight the connection with the EAS society fostering collaboration with young researchers and peers. I hope this project will unravel the intricate connection between mitochondria and lipoprotein metabolism in the development of Atherosclerosis.“
Umesh Tharehalli Mathada
Department of Pediatrics, University Medical Center Groningen, The Netherlands
Project: Targeting VLDL metabolism as a means to treat cardiometabolic patients. A role for the liver clock?
“I am honored to receive the EAS Grant. I thank EAS for recognizing this project and my research lab for their immense support. With the grant’s resources, I look forward to achieving a milestone on this project.”
Department of Cardiology and Vascular Medicine, Amsterdam UMC, The Netherlands
Project: Inflammatory Plaque Disguised in Coronary Atherosclerosis: Revealing the Invisible (INDRI)
“I am very honored and happy to be receiving this EAS grant. I am grateful to the EAS for this opportunity to further investigate the role of inflammation in atherosclerosis using cardiac CT imaging. I can’t wait to initiate this project.”
Enhancing credibility: introducing the new membership process
Dear EAS members,
In response to the fast-paced environment that characterizes our world, we are introducing modifications to our membership application process, effective from January 1, 2024. This adjustment is aimed at ensuring the integrity of the EAS community by aligning with the highest standards of scientific credibility.
To achieve this, all applicants, both new and existing individual members, will be required to submit two documents verifying their eligibility based on the criteria outlined in our bylaws.
We strive to keep the procedure as efficient and straightforward as possible.
The details of the new application process will be outlined on our website, social media platforms, and newsletters in the upcoming days.
We kindly request both new and existing individual members to submit two of the following documents:
· Scientific article authored by the applicant
· Letter showing applicant’s status of employment or study
· Letter of recommendation from an existing EAS individual member
· Congress abstract or similar presented by the applicant
Additionally, as we expand our portfolio of benefits and educational activities, we recognize the need to adjust our membership fees to sustain the quality of services provided.
The current fees, established in 2009, will be increased:
– from €40 to €60 for individuals over 35 years old
– from €20 to €30 for individuals aged 35 and younger
EAS has designed membership packages that not only provide excellent value but also frequently offer individual benefits that are more costly when acquired independently We believe these fees are reasonable considering the extensive range of activities we offer and plan to provide in the future.
We appreciate your understanding and support as we navigate these changes together. We are confident that everyone will benefit from these changes.
Thank you for being an integral part of the European Atherosclerosis Society.
Webinar: Inflammation in a Translational Perspective is almost here. Last call to register
With less than 24 hours left, secure your spot for tomorrow’s webinar: Inflammation in a Translational Perspective. Take advantage of the chance to gain insights from the experts, and get ready to enhance the discussion by preparing your questions for them!
Join others who’ve already signed up:Go to registration page
Secure your full individual EAS membership by December 31, 2023 to take advantage of the reduced congress fee
As in the previous years, we encourage you to secure your full individual EAS membership by December 31, 2023 to take advantage of the reduced congress fee.
This exclusive offer is a valuable benefit of your membership, providing you with cost-effective access to the upcoming congress. Don’t miss out on this opportunity to save on registration fees and enhance your experience as a member of the EAS community.
Ensure your membership is confirmed before the deadline to enjoy these privileges.Learn more about EAS membership
Webinar presented by the EAS Lipid Clinic Network, New perspectives of lipid-lowering therapies
Join us for an upcoming educational webinar hosted by the EAS Lipid Clinic Network (LCN). This webinar focuses on “New perspectives of lipid-lowering therapies”.
This 30-minute session promises to be both engaging and interactive, featuring a presentation by Professor Alberico L. Catapano. Following the presentation, we invite you to participate in a live Q&A session.
Date: Tuesday, November 21st
Time: 17:00 CEST
Kindly register through the following link:Go to registration page
Recent issue highlights – August 2023
Chronic inflammation is both a pathogenic factor and a characteristic response of atherosclerotic lesions. The inflammation is, therefore, targeted for diagnostics/prognostics, as well as therapy of atherosclerotic cardiovascular diseases. The two first August issues of Atherosclerosis contain several articles that cover these aspects of inflammation in atherosclerosis.August issue vol. 378 & 379
Issues 380 and 381 of Atherosclerosis contain several articles that describe the use of non-invasive methods for the assessment of manifest or emerging atherosclerotic cardiovascular diseases for differential diagnosis or prognosis.August issue vol. 380 & 381
Consuming a healthy diet is associated with lower cardiovascular disease risk in all regions of the world
Consuming a healthy diet is associated with lower cardiovascular disease risk in all regions of the world. A recent analysis of the Prospective Urban Rural Epidemiology (PURE) study, involving over 147,000 individuals from 21 countries, has uncovered compelling evidence supporting the role of a healthy diet in reducing the risk of cardiovascular disease (CVD) and total mortality globally.
Explore the latest addition to “The Diet at the Heart” series.6. Consuming a healthy diet is associated with lower cardiovascular disease risk in all regions of the worldTo the Diet at the Heart article series